Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Grupo Aeroportuario del Sureste, S. A. B. de C. V. stock logo
ASR
Grupo Aeroportuario del Sureste, S. A. B. de C. V.
$340.64
+1.1%
$314.29
$165.00
$357.90
$10.22B1.1542,515 shs25,591 shs
ELD
WisdomTree Emerging Markets Local Debt Fund
$26.88
+0.5%
$27.22
$25.01
$28.59
$83.32M0.3516,302 shs9,632 shs
IAMGOLD Co. stock logo
IMG
IAMGOLD
C$4.93
-1.6%
C$4.52
C$2.71
C$5.38
C$2.45B1.441.26 million shs1.01 million shs
SBM
ProShares Short Basic Materials
$46.38
$46.38
$42.85
$55.15
$1.86MN/A3,024 shsN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
$27.48
+4.5%
$35.81
$24.60
$63.57
$3.27B1.941.97 million shs2.39 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Grupo Aeroportuario del Sureste, S. A. B. de C. V. stock logo
ASR
Grupo Aeroportuario del Sureste, S. A. B. de C. V.
+1.07%-3.93%+5.29%+12.24%+19.42%
ELD
WisdomTree Emerging Markets Local Debt Fund
+0.22%+0.49%-2.01%-3.70%-1.11%
IAMGOLD Co. stock logo
IMG
IAMGOLD
-1.60%-4.83%-0.20%+47.60%+16.55%
SBM
ProShares Short Basic Materials
0.00%0.00%0.00%0.00%-0.01%
10x Genomics, Inc. stock logo
TXG
10x Genomics
+4.53%-0.40%-24.40%-36.97%-49.11%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Grupo Aeroportuario del Sureste, S. A. B. de C. V. stock logo
ASR
Grupo Aeroportuario del Sureste, S. A. B. de C. V.
1.3813 of 5 stars
1.33.02.50.03.00.01.9
ELD
WisdomTree Emerging Markets Local Debt Fund
N/AN/AN/AN/AN/AN/AN/AN/A
IAMGOLD Co. stock logo
IMG
IAMGOLD
0.6869 of 5 stars
1.20.01.70.02.51.71.3
SBM
ProShares Short Basic Materials
N/AN/AN/AN/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
4.4253 of 5 stars
4.31.00.04.81.63.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Grupo Aeroportuario del Sureste, S. A. B. de C. V. stock logo
ASR
Grupo Aeroportuario del Sureste, S. A. B. de C. V.
2.50
Moderate Buy$274.00-19.56% Downside
ELD
WisdomTree Emerging Markets Local Debt Fund
0.00
N/AN/AN/A
IAMGOLD Co. stock logo
IMG
IAMGOLD
2.40
HoldC$4.991.29% Upside
SBM
ProShares Short Basic Materials
0.00
N/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
2.58
Moderate Buy$48.5076.49% Upside

Current Analyst Ratings

Latest ASR, IMG, SBM, TXG, and ELD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$52.00 ➝ $30.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$30.00 ➝ $26.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$45.00 ➝ $36.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$63.00 ➝ $53.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$57.00 ➝ $32.00
4/29/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$65.00 ➝ $50.00
4/23/2024
IAMGOLD Co. stock logo
IMG
IAMGOLD
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$3.75 ➝ C$5.50
4/19/2024
IAMGOLD Co. stock logo
IMG
IAMGOLD
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$6.25 ➝ C$6.50
4/19/2024
IAMGOLD Co. stock logo
IMG
IAMGOLD
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$3.00 ➝ C$5.25
4/18/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$60.00 ➝ $55.00
4/10/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$55.00 ➝ $45.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Grupo Aeroportuario del Sureste, S. A. B. de C. V. stock logo
ASR
Grupo Aeroportuario del Sureste, S. A. B. de C. V.
$26.81B0.38$23.36 per share14.58$97.16 per share3.51
ELD
WisdomTree Emerging Markets Local Debt Fund
N/AN/AN/AN/AN/AN/A
IAMGOLD Co. stock logo
IMG
IAMGOLD
C$987.10M2.48C$1.98 per share2.49C$4.58 per share1.08
SBM
ProShares Short Basic Materials
N/AN/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
$618.73M5.29N/AN/A$6.03 per share4.56

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Grupo Aeroportuario del Sureste, S. A. B. de C. V. stock logo
ASR
Grupo Aeroportuario del Sureste, S. A. B. de C. V.
$576.51M$21.1516.1112.643.1340.21%22.21%15.64%7/22/2024 (Estimated)
ELD
WisdomTree Emerging Markets Local Debt Fund
N/AN/A0.00N/AN/AN/AN/AN/A
IAMGOLD Co. stock logo
IMG
IAMGOLD
C$88MC$0.2420.54N/A9.55%4.36%-0.02%5/9/2024 (Confirmed)
SBM
ProShares Short Basic Materials
N/AN/A0.00N/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$255.10M-$2.23N/AN/AN/A-42.20%-30.85%-24.17%8/1/2024 (Estimated)

Latest ASR, IMG, SBM, TXG, and ELD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
IAMGOLD Co. stock logo
IMG
IAMGOLD
C$0.02N/A-C$0.02N/AN/AN/A
4/30/2024Q1 2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.50-$0.50N/A-$0.50$142.24 million$141.01 million    
2/26/2024Q4 2023
Grupo Aeroportuario del Sureste, S. A. B. de C. V. stock logo
ASR
Grupo Aeroportuario del Sureste, S. A. B. de C. V.
$5.78$4.99-$0.79$4.99N/A$392.31 million
2/15/2024Q4 2023
IAMGOLD Co. stock logo
IMG
IAMGOLD
C$0.02C$0.08+C$0.06C$0.19N/AC$405.19 million
2/15/2024Q4 2023
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.36-$0.41-$0.05-$0.41$182.73 million$183.98 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Grupo Aeroportuario del Sureste, S. A. B. de C. V. stock logo
ASR
Grupo Aeroportuario del Sureste, S. A. B. de C. V.
$5.071.49%N/A23.97%N/A
ELD
WisdomTree Emerging Markets Local Debt Fund
$1.365.06%N/AN/AN/A
IAMGOLD Co. stock logo
IMG
IAMGOLD
N/AN/AN/AN/AN/A
SBM
ProShares Short Basic Materials
N/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Debt

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Grupo Aeroportuario del Sureste, S. A. B. de C. V. stock logo
ASR
Grupo Aeroportuario del Sureste, S. A. B. de C. V.
1,88230.00 millionN/AOptionable
ELD
WisdomTree Emerging Markets Local Debt Fund
N/A3.10 millionN/ANot Optionable
IAMGOLD Co. stock logo
IMG
IAMGOLD
3,600496.63 millionN/ANot Optionable
SBM
ProShares Short Basic Materials
N/A40,000N/ANot Optionable
10x Genomics, Inc. stock logo
TXG
10x Genomics
1,259119.17 million106.48 millionOptionable

ASR, IMG, SBM, TXG, and ELD Headlines

SourceHeadline
Vestmark Advisory Solutions Inc. Makes New $4.33 Million Investment in 10x Genomics, Inc. (NASDAQ:TXG)Vestmark Advisory Solutions Inc. Makes New $4.33 Million Investment in 10x Genomics, Inc. (NASDAQ:TXG)
marketbeat.com - May 4 at 2:39 PM
Research Analysts Issue Forecasts for 10x Genomics, Inc.s Q2 2024 Earnings (NASDAQ:TXG)Research Analysts Issue Forecasts for 10x Genomics, Inc.'s Q2 2024 Earnings (NASDAQ:TXG)
americanbankingnews.com - May 4 at 1:42 AM
Q2 2024 Earnings Estimate for 10x Genomics, Inc. Issued By William Blair (NASDAQ:TXG)Q2 2024 Earnings Estimate for 10x Genomics, Inc. Issued By William Blair (NASDAQ:TXG)
marketbeat.com - May 3 at 7:28 AM
10x Genomics (NASDAQ:TXG) PT Lowered to $36.0010x Genomics (NASDAQ:TXG) PT Lowered to $36.00
americanbankingnews.com - May 3 at 5:14 AM
10x Genomics (NASDAQ:TXG) Stock Rating Lowered by TD Cowen10x Genomics (NASDAQ:TXG) Stock Rating Lowered by TD Cowen
americanbankingnews.com - May 3 at 5:14 AM
The Goldman Sachs Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $26.00The Goldman Sachs Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $26.00
americanbankingnews.com - May 3 at 5:14 AM
Stifel Nicolaus Lowers 10x Genomics (NASDAQ:TXG) Price Target to $53.00Stifel Nicolaus Lowers 10x Genomics (NASDAQ:TXG) Price Target to $53.00
americanbankingnews.com - May 3 at 5:14 AM
10x Genomics (NASDAQ:TXG) PT Lowered to $30.0010x Genomics (NASDAQ:TXG) PT Lowered to $30.00
americanbankingnews.com - May 3 at 5:14 AM
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
prnewswire.com - May 2 at 4:05 PM
TD Cowen Downgrades 10x Genomics (TXG)TD Cowen Downgrades 10x Genomics (TXG)
msn.com - May 2 at 7:37 AM
10x Genomics First Quarter 2024 Earnings: In Line With Expectations10x Genomics First Quarter 2024 Earnings: In Line With Expectations
finance.yahoo.com - May 2 at 7:37 AM
10x Genomics, Inc: 10x Genomics Reports First Quarter 2024 Financial Results10x Genomics, Inc: 10x Genomics Reports First Quarter 2024 Financial Results
finanznachrichten.de - May 2 at 2:37 AM
10x Genomics (NASDAQ:TXG) Sets New 12-Month Low After Analyst Downgrade10x Genomics (NASDAQ:TXG) Sets New 12-Month Low After Analyst Downgrade
americanbankingnews.com - May 2 at 1:18 AM
10x Genomics (NASDAQ:TXG) Given New $30.00 Price Target at UBS Group10x Genomics (NASDAQ:TXG) Given New $30.00 Price Target at UBS Group
marketbeat.com - May 1 at 2:32 PM
10x Genomics (NASDAQ:TXG) Hits New 12-Month Low After Analyst Downgrade10x Genomics (NASDAQ:TXG) Hits New 12-Month Low After Analyst Downgrade
marketbeat.com - May 1 at 11:34 AM
Analysts’ Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)Analysts’ Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)
markets.businessinsider.com - May 1 at 8:41 AM
10x Genomics (NASDAQ:TXG) Downgraded by TD Cowen10x Genomics (NASDAQ:TXG) Downgraded by TD Cowen
marketbeat.com - May 1 at 8:32 AM
Canaccord Genuity Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $50.00Canaccord Genuity Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $50.00
americanbankingnews.com - May 1 at 5:32 AM
10x Genomics Inc (TXG) (Q1 2024) Earnings Call Transcript Highlights: Diverse Revenue Streams ...10x Genomics Inc (TXG) (Q1 2024) Earnings Call Transcript Highlights: Diverse Revenue Streams ...
finance.yahoo.com - May 1 at 3:41 AM
Curio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)Curio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)
businesswire.com - May 1 at 1:01 AM
10x Genomics: Q1 Earnings Snapshot10x Genomics: Q1 Earnings Snapshot
sfgate.com - April 30 at 10:41 PM
TXG Stock Earnings: 10x Genomics Meets EPS, Misses Revenue for Q1 2024TXG Stock Earnings: 10x Genomics Meets EPS, Misses Revenue for Q1 2024
markets.businessinsider.com - April 30 at 10:41 PM
10x Genomics (TXG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates10x Genomics (TXG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com - April 30 at 7:31 PM
10x Genomics Inc (TXG) Q1 2024 Earnings: Misses Analyst Expectations Amidst New Product Launches10x Genomics Inc (TXG) Q1 2024 Earnings: Misses Analyst Expectations Amidst New Product Launches
finance.yahoo.com - April 30 at 6:17 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Grupo Aeroportuario del Sureste, S. A. B. de C. V. logo

Grupo Aeroportuario del Sureste, S. A. B. de C. V.

NYSE:ASR
Grupo Aeroportuario del Sureste, S. A. B. de C. V. holds concessions to operate, maintain, and develop airports in the southeast region of Mexico. The company operates airports that are located in the cities of Cancún, Cozumel, Mérida, Huatulco, Oaxaca, Veracruz, Villahermosa, Tapachula, and Minatitlán. It provides aeronautical services, which include passenger, aircraft landing and parking, passenger walkway, and airport security services. The company also offers non-aeronautical services, such as leasing of space at its airports to retailers, restaurants, airlines, and other commercial tenants; catering, handling, and ground transportation services, as well as engages in the various commercial operations. In addition, it holds concessions to operate the Luis Muñoz Marín International Airport in San Juan, Puerto Rico; and various airports in Colombia, including the Enrique Olaya Herrera Airport in Medellín, the José María Córdova International Airport in Rionegro, the Los Garzones Airport in Montería, the Antonio Roldán Betancourt Airport in Carepa, the El Caraño Airport in Quibdó, and the Las Brujas Airport in Corozal. Grupo Aeroportuario del Sureste, S. A. B. de C. V. was founded in 1996 and is headquartered in Mexico City, Mexico.

WisdomTree Emerging Markets Local Debt Fund

NYSEARCA:ELD
The WisdomTree Emerging Markets Local Debt Fund (ELD) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund is actively managed and invests in both investment- and non-investment-grade government and corporate bonds from emerging countries denominated in local currencies. ELD was launched on Aug 9, 2010 and is managed by WisdomTree.
IAMGOLD logo

IAMGOLD

TSE:IMG
IAMGOLD Corporation, through its subsidiaries, operates as an intermediate gold producer and developer in Canada and Burkina Faso. It owns 100% interest in the Westwood project that covers an area of 1,925 hectare and located in Quebec; a 60% interest in the Côté gold project, which covers an area of 596 square kilometer located in Ontario, Canada; and a 90% interests in the Essakane project that covers an area of 274,000 square kilometer situated in Burkina Faso. IAMGOLD Corporation was incorporated in 1990 and is headquartered in Toronto, Canada.

ProShares Short Basic Materials

NYSEARCA:SBM
ProShares Short Basic Materials (the Fund) seeks daily investment results that correspond to the inverse (opposite) of the daily performance of Dow Jones U.S. Basic Materials Index (the Index). The Index measures the performance of the basic materials industry of the United States equity market. The Fund invests in derivatives as a substitute for directly shorting stocks in order to gain inverse exposure to the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. The Fund also invests in short-term cash instruments that have terms to maturity of less than 397 days and exhibit credit profiles. ProShare Advisors LLC is the investment advisor of the Fund.
10x Genomics logo

10x Genomics

NASDAQ:TXG
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.